Bilcare Ltd

Shares of Bilcare Ltd, a micro-cap player in the Healthcare Services sector, declined sharply to hit a new 52-week low of Rs.53.02 on 17 Mar 2026, marking a significant downturn in the stock’s performance amid ongoing financial and market pressures.

Shares of Bilcare Ltd, a player in the Healthcare Services sector, declined to a fresh 52-week low of Rs.54 today, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects persistent pressures on the company’s valuation amid broader market weakness and company-specific factors.

Bilcare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 18 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 13 March 2026, providing investors with the latest insights into its performance and prospects.

Shares of Bilcare Ltd, a player in the Healthcare Services sector, declined sharply to hit a new 52-week low of Rs.55 on 9 Mar 2026, marking a significant downturn in the stock’s performance amid broader market pressures and company-specific concerns.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Bilcare Ltd, a player in the Healthcare Services sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. Despite the stagnant revenue growth, the company has demonstrated notable improvements in operating margins and cash reserves, prompting a reassessment of its financial outlook.

Bilcare Ltd., a research-based pharmaceutical packaging solutions provider, reported a consolidated net loss of ₹5.95 crores for Q3 FY26, marking a 51.86% sequential deterioration from the previous quarter's loss of ₹12.36 crores. The company's struggles intensified despite marginal revenue growth, with the stock plunging 5.02% to ₹63.00 following the results announcement, reflecting investor concerns about the company's persistent inability to achieve profitability.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with the latest insights into its performance and outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with the most recent insights into its performance and outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Bilcare, a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and operational metrics. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trajectory, and technical outlook amid a volatile market environment.

Bilcare Ltd has witnessed extraordinary buying momentum, registering a near 10% gain in a single session with no sellers in the queue, signalling a potential multi-day upper circuit scenario. This surge stands in stark contrast to the broader market’s modest gains, underscoring a remarkable investor appetite for the healthcare services stock.

Bilcare, a microcap in healthcare services, has faced significant financial challenges for the quarter ending September 2025, with a notable decline in key performance metrics. Despite achieving a high liquidity position, the company reported a substantial loss in profit after tax and low net sales, indicating operational difficulties.